Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action).
CONCLUSIONS: These studies demonstrate the effective acid neutralizing capacity of Gaviscon DA versus placebo in healthy, fasted subjects. This adds to the evidence base for the combination of alginates and antacids. [Eudra CT 2014-003158-15; 2016-000539-42].
PMID: 30470147 [PubMed - as supplied by publisher]
Source: Drug Development and Industrial Pharmacy - Category: Drugs & Pharmacology Tags: Drug Dev Ind Pharm Source Type: research
More News: Acid Reflux | Drugs & Pharmacology | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Germany Health | Study